help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kennedy, A. R.
Right arrow Articles by Bloom, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kennedy, A. R.
Right arrow Articles by Bloom, S. R.
Endocrinology Vol. 142, No. 7 3265
Copyright © 2001 by The Endocrine Society


ARTICLES

Melanin-Concentrating Hormone (MCH) Suppresses Thyroid Stimulating Hormone (TSH) release, in Vivo and in Vitro, via the Hypothalamus and the Pituitary

A. R. Kennedy, J. F. Todd, S. A. Stanley, C. R. Abbott, C. J. Small, M. A. Ghatei and S. R. Bloom

Endocrine unit, Imperial College School of Medicine, Hammersmith Hospital, Du Cane Road, London, W12 ONN UK

Abstract

Melanin-concentrating hormone (MCH) is an orexigenic peptide encoded in the pre-pro MCH gene. Targeted deletion of MCH causes a phenotype of hypophagia and leanness with an inappropriately high metabolic rate, suggesting a role for MCH in the control of energy balance. In order to further elucidate the mechanism by which MCH controls, energy expenditure, we have investigated the effects of MCH on the hypothalamic pituitary thyroid (HPT) axis. The thyroid axis is important in energy homeostasis and starvation leads to profound suppression of the HPT axis.

MCH significantly reduces plasma TSH in vivo at 10 min (0.5 ± 0.07 ng/ml, p < 0.05, n = 8) and 60 min (0.33 ± 0.04 ng/ml, p < 0.01, n = 10) compared to saline (0.7 ± 0.07 ng/ml and 0.69 ± 0.07 ng/ml respectively) when administered intracerebroventricularly. Release of TRH form hypothalamic explants was significantly reduced in the presence of MCH production (7.1 ± 0.99 fmol/explant to 2.3 ± 0.4 fmol/explant p < 0.01, n = 18) and Neuropeptide EI (NEI) (8.47 ± 1.28 fmol/explant to 4.6 ± 1.13 p < 0.05, n = 16), a peptide, also encoded in the pre-pro-MCH gene. MCH was also shown to significantly reduce TRH stimulated TSH release from dispersed pituitary cell cultures (basal = 0.5 ± 0.06 ng/ml, 100 nM TRH = 0.9 ± 0.2 ng/ml, p < 0.05 0.1 nM MCH = 0.5 ± 0.1 ng/ml, p < 0.05, 1 nM MCH = 0.3 ± 0.03 ng/ml, p < 0.01, 10 nM MCH = 0.4 ± 0.02 ng/ml, p < 0.01, 1000 nM MCH = 0.4 ± 0.05 ng/ml, P < 0.01, n = 4), although basal release of TSH from these cultures was unaffected.

These data suggest a possible role for MCH in the control of energy homeostasis via inhibition of the thyroid axis.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
P. Pissios, R. L. Bradley, and E. Maratos-Flier
Expanding the Scales: The Multiple Roles of MCH in Regulating Energy Balance and Other Biological Functions
Endocr. Rev., October 1, 2006; 27(6): 606 - 620.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Pissios, D. J. Trombly, I. Tzameli, and E. Maratos-Flier
Melanin-Concentrating Hormone Receptor 1 Activates Extracellular Signal-Regulated Kinase and Synergizes with Gs-Coupled Pathways
Endocrinology, August 1, 2003; 144(8): 3514 - 3523.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Ito, A. Gomori, A. Ishihara, Z. Oda, S. Mashiko, H. Matsushita, M. Yumoto, M. Ito, H. Sano, S. Tokita, et al.
Characterization of MCH-mediated obesity in mice
Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E940 - E945.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Gomori, A. Ishihara, M. Ito, S. Mashiko, H. Matsushita, M. Yumoto, M. Ito, T. Tanaka, S. Tokita, M. Moriya, et al.
Chronic intracerebroventricular infusion of MCH causes obesity in mice
Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E583 - E588.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Chen, C. Hu, C.-K. Hsu, Q. Zhang, C. Bi, M. Asnicar, H. M. Hsiung, N. Fox, L. J. Slieker, D. D. Yang, et al.
Targeted Disruption of the Melanin-Concentrating Hormone Receptor-1 Results in Hyperphagia and Resistance to Diet-Induced Obesity
Endocrinology, July 1, 2002; 143(7): 2469 - 2477.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. J. Marsh, D. T. Weingarth, D. E. Novi, H. Y. Chen, M. E. Trumbauer, A. S. Chen, X.-M. Guan, M. M. Jiang, Y. Feng, R. E. Camacho, et al.
Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism
PNAS, February 20, 2002; (2002) 52706899.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. J. Marsh, D. T. Weingarth, D. E. Novi, H. Y. Chen, M. E. Trumbauer, A. S. Chen, X.-M. Guan, M. M. Jiang, Y. Feng, R. E. Camacho, et al.
Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism
PNAS, March 5, 2002; 99(5): 3240 - 3245.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society